Holm R - Search Results

1

TP53 protein accumulation and gene mutation in relation to overexpression of MDM2 protein in ovarian borderline tumours and stage I carcinomas.

Skomedal H, Kristensen GB, Abeler VM, Børresen-Dale AL, Tropé C, Holm R. Skomedal H, et al. Among authors: holm r. J Pathol. 1997 Feb;181(2):158-65. doi: 10.1002/(SICI)1096-9896(199702)181:2<158::AID-PATH742>3.0.CO;2-8. J Pathol. 1997. PMID: 9120719

2

Effect of the codon 72 polymorphism (c.215G>C, p.Arg72Pro) in combination with somatic sequence variants in the TP53 gene on survival in patients with advanced ovarian carcinoma.

Wang Y, Kringen P, Kristensen GB, Holm R, Baekelandt MM, Olivier M, Skomedal H, Hainaut P, Tropé CG, Abeler VM, Nesland JM, Børresen-Dale AL, Helland A. Wang Y, et al. Among authors: holm r. Hum Mutat. 2004 Jul;24(1):21-34. doi: 10.1002/humu.20055. Hum Mutat. 2004. PMID: 15221786

3

PIK3CA mutations in advanced ovarian carcinomas.

Wang Y, Helland A, Holm R, Kristensen GB, Børresen-Dale AL. Wang Y, et al. Among authors: holm r. Hum Mutat. 2005 Mar;25(3):322. doi: 10.1002/humu.9316. Hum Mutat. 2005. PMID: 15712344

4

Protein expression and prognostic value of genes in the erb-b signaling pathway in advanced ovarian carcinomas.

Wang Y, Kristensen GB, Helland A, Nesland JM, Børresen-Dale AL, Holm R. Wang Y, et al. Among authors: holm r. Am J Clin Pathol. 2005 Sep;124(3):392-401. doi: 10.1309/BL7E-MW66-LQX6-GFRP. Am J Clin Pathol. 2005. PMID: 16191507

5

TP53 gene mutations and protein accumulation in primary vaginal carcinomas.

Skomedal H, Kristensen G, Helland A, Nesland JM, Kooi S, Børresen AL, Holm R. Skomedal H, et al. Among authors: holm r. Br J Cancer. 1995 Jul;72(1):129-33. doi: 10.1038/bjc.1995.288. Br J Cancer. 1995. PMID: 7599041 Free PMC article.

6

Overexpression of p53 protein and c-erbB-2 protein in small cell carcinoma of the cervix uteri.

Holm R, Abeler VM, Skomedal H, Nesland JM. Holm R, et al. Zentralbl Pathol. 1993 Jun;139(2):153-6. Zentralbl Pathol. 1993. PMID: 8103676

7

Genetic alterations of the TP53 gene, p53 protein expression and HPV infection in primary cervical carcinomas.

Helland A, Holm R, Kristensen G, Kaern J, Karlsen F, Trope C, Nesland JM, Børresen AL. Helland A, et al. Among authors: holm r. J Pathol. 1993 Oct;171(2):105-14. doi: 10.1002/path.1711710207. J Pathol. 1993. PMID: 8283348

8

Immunohistochemical analysis of p53 protein overexpression in normal, premalignant, and malignant tissues of the cervix uteri.

Holm R, Skomedal H, Helland A, Kristensen G, Børresen AL, Nesland JM. Holm R, et al. J Pathol. 1993 Jan;169(1):21-6. doi: 10.1002/path.1711690105. J Pathol. 1993. PMID: 8433212

9

Evaluation of the prognostic significance of nm23/NDP kinase protein expression in cervical carcinoma: an immunohistochemical study.

Kristensen GB, Holm R, Abeler VM, Tropé CG. Kristensen GB, et al. Among authors: holm r. Gynecol Oncol. 1996 Jun;61(3):378-83. doi: 10.1006/gyno.1996.0160. Gynecol Oncol. 1996. PMID: 8641619

10

A comparison of different modes for the detection of p53 protein accumulation. A study of bladder cancer.

Kraggerud SM, Jacobsen KD, Berner A, Stokke T, Holm R, Smedshammer L, Børresen-Dale AL, Fosså SD. Kraggerud SM, et al. Among authors: holm r. Pathol Res Pract. 1997;193(7):471-8. doi: 10.1016/s0344-0338(97)80099-4. Pathol Res Pract. 1997. PMID: 9342752

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

857 results

Search Page

Filters